GENIAL annual general meeting

On June 11 and 12, 2025, the GENIAL project held its first Annual General Meeting. The event gathered leading researchers, clinicians, and patient advocates to review the project’s progress and align on next steps. GENIAL is a Horizon Europe-funded project focused on alcohol-related hepatocellular carcinoma (ALD-HCC). It aims to uncover genetic risk factors, explore the role of environmental and lifestyle factors, and develop AI-powered tools to predict individual risk and guide early intervention. The project is structured around four main pillars:
Identifying genetic variants linked to ALD-HCC.
Investigating gene–environment interactions at cellular and molecular levels.
Characterizing environmental risk factors in large European populations.
Enhancing public awareness and stakeholder engagement through strategic communication.
The European Liver Patients’ Association (ELPA) leads the project’s communication and dissemination activities. ELPA ensures that complex scientific findings are translated into accessible information for patients, healthcare professionals, and the public. Through its broad network, ELPA facilitates meaningful patient involvement and contributes to shaping patient-centered outcomes.